Exact Mass: 273.2092532

Exact Mass Matches: 273.2092532

Found 216 metabolites which its exact mass value is equals to given mass value 273.2092532, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fenpropidin

1-(2-Methyl-3-(4-(2-methyl-2-propanyl)phenyl)propyl)piperidine

C19H31N (273.2456366)


CONFIDENCE standard compound; INTERNAL_ID 8461 CONFIDENCE standard compound; INTERNAL_ID 2589 D016573 - Agrochemicals D010575 - Pesticides

   

(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine

(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine

C12H23N3O4 (273.1688478)


   

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2092532)


N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices. N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is a constituent of Zanthoxylum piperitum (Japanese pepper tree) and other Zanthoxylum species Constituent of Zanthoxylum piperitum (Japanese pepper tree) and other Zanthoxylum subspecies N-Isobutyl-2,4,8,10,12-tetradecapentaenamide is found in herbs and spices.

   

Valylarginine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.18008080000004)


Valylarginine is a dipeptide composed of valine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginylvaline

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C11H23N5O3 (273.18008080000004)


Arginylvaline is a dipeptide composed of arginine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Heptanoylcarnitine

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.1939982)


Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

Linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

C17H23NO2 (273.1728698)


Linalyl anthranilate is used in food flavourin It is used in food flavouring.

   

alpha-Terpinyl anthranilate

2-(4-Methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoic acid

C17H23NO2 (273.1728698)


alpha-Terpinyl anthranilate is a flavouring ingredient with a complex fruity odour and bitter taste. Flavouring ingredient with a complex fruity odour and bitter taste

   

4-Methylhexanoylcarnitine

3-[(4-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.1939982)


4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylhexanoylcarnitine

3-[(5-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.1939982)


5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylhexanoylcarnitine

3-[(3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.1939982)


3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine

1-[1-(3-methoxyphenyl)cyclohexyl]piperidine

C18H27NO (273.2092532)


   

4-Methoxyphencyclidine

4-methoxy-1-(1-phenylcyclohexyl)piperidine

C18H27NO (273.2092532)


   

4-Methylpropranolol

1-[(4-methylnaphthalen-1-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol

C17H23NO2 (273.1728698)


   

Dextilidine

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylic acid

C17H23NO2 (273.1728698)


   

gamma-Sanshool

N-(2-Methylpropyl)tetradeca-2,4,8,10,12-pentaenimidate

C18H27NO (273.2092532)


   

Valyl-Arginine

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.18008080000004)


   
   
   
   

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

C17H23NO2 (273.1728698)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   
   

1-(1-(4-Methoxyphenyl)cyclohexyl)piperidine

1-(1-(4-Methoxyphenyl)cyclohexyl)piperidine

C18H27NO (273.2092532)


   

3-meo-pcp

1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine

C18H27NO (273.2092532)


   
   
   
   

tetradeca-2E-ene-10,12-diynoic acid isobutylamide

tetradeca-2E-ene-10,12-diynoic acid isobutylamide

C18H27NO (273.2092532)


   

N-isobutyl-6-(p-methoxyphenyl)hexa-3,5-dienamide

N-isobutyl-6-(p-methoxyphenyl)hexa-3,5-dienamide

C17H23NO2 (273.1728698)


   

2,4,10-Tetradecatrien-8-ynoic acid isobutylamide

2,4,10-Tetradecatrien-8-ynoic acid isobutylamide

C18H27NO (273.2092532)


   
   
   

2,4,8,11-Tetradecatetraenoic acid|tetradeca-2E,4E,8Z,11Z-tetraenoic acid pyrrolidide

2,4,8,11-Tetradecatetraenoic acid|tetradeca-2E,4E,8Z,11Z-tetraenoic acid pyrrolidide

C18H27NO (273.2092532)


   

1-Methyl-8-methoxy-2-hexylquinolin-4(1H)-one

1-Methyl-8-methoxy-2-hexylquinolin-4(1H)-one

C17H23NO2 (273.1728698)


   

6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide

6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide

C17H23NO2 (273.1728698)


   
   
   
   
   

2,4-Tetradecadien-8-ynoic acid pyrrolidide|tetrradeca-2E,4E-dien-8-ynoic acid pyrrolidide

2,4-Tetradecadien-8-ynoic acid pyrrolidide|tetrradeca-2E,4E-dien-8-ynoic acid pyrrolidide

C18H27NO (273.2092532)


   
   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide

C17H23NO2 (273.1728698)


   
   
   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide

C17H23NO2 (273.1728698)


   
   
   
   
   
   
   
   
   
   
   
   

gamma-Sanshool

gamma-Sanshool

C18H27NO (273.2092532)


An enamide obtained by the formal condensation of 2-methylpropanamine with tetradeca-2,4,8,10,12-pentaenoic acid (the 2E,4E,8Z,10E,12E stereoisomer). Isolated from Zanthoxylum piperitum, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase.

   

Fenpropidin

Fenpropidin

C19H31N (273.2456366)


D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 2958

   

Tilidine

Tilidine

C17H23NO2 (273.1728698)


N - Nervous system > N02 - Analgesics > N02A - Opioids CONFIDENCE standard compound; EAWAG_UCHEM_ID 3329

   

NVE_274.1802_16.6

NVE_274.1802_16.6

C17H23NO2 (273.1728698)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1207

   

4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8

4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8

C17H23NO2 (273.1728698)


   
   
   
   
   
   
   

(E)-8-(but-3-en-1-yl)-5-(hepta-4,6-dien-1-yl)octahydroindolizine

(E)-8-(but-3-en-1-yl)-5-(hepta-4,6-dien-1-yl)octahydroindolizine

C19H31N (273.2456366)


   

(5R,6R,8R)-6,8-dimethyl-5-((E)-non-6-en-8-yn-1-yl)octahydroindolizine

(5R,6R,8R)-6,8-dimethyl-5-((E)-non-6-en-8-yn-1-yl)octahydroindolizine

C19H31N (273.2456366)


   

10Z,13Z,16Z-nonadecatrienenitrile

10Z,13Z,16Z-nonadecatrienenitrile

C19H31N (273.2456366)


   

Arg-val

2-(2-amino-3-methylbutanamido)-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.18008080000004)


A dipeptide formed from L-arginine and L-valine residues.

   

Val-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-methylbutanoic acid

C11H23N5O3 (273.18008080000004)


A dipeptide formed from L-valine and L-asparagine residues.

   

linalyl anthranilate

Anthranilic acid, 1, 5-dimethyl-1-vinyl-4-hexenyl ester

C17H23NO2 (273.1728698)


   

g-Sanshool

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2092532)


   

FEMA 3048

2-(4-methylcyclohex-3-en-1-yl)propan-2-yl 2-aminobenzoate

C17H23NO2 (273.1728698)


   

1-(p-Methoxyphenyl)-5-piperidino-1-penten-3-one

(E)-1-(4-methoxyphenyl)-5-piperidin-1-ylpent-1-en-3-one;hydrochloride

C17H23NO2 (273.1728698)


   

CAR 7:0

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.1939982)


   

NA 18:5

(2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide

C18H27NO (273.2092532)


   

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

C14H11D8NO4 (273.181618824)


   

ISONIPECOTIC ACID, 1-ALLYL-4-PHENYL-, ETHYL ESTER

ISONIPECOTIC ACID, 1-ALLYL-4-PHENYL-, ETHYL ESTER

C17H23NO2 (273.1728698)


   

2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline

2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline

C17H23NO2 (273.1728698)


   

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

C16H24BNO2 (273.1899994)


   

9-((tert-Butoxycarbonyl)amino)nonanoic acid

9-((tert-Butoxycarbonyl)amino)nonanoic acid

C14H27NO4 (273.1939982)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

C16H24BNO2 (273.1899994)


   

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C14H27NO4 (273.1939982)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

C16H24BNO2 (273.1899994)


   

N-BIS(TERT-BUTYLPROPIONATE)AMINE

N-BIS(TERT-BUTYLPROPIONATE)AMINE

C14H27NO4 (273.1939982)


   

1-(Triisopropylsilyl)-1H-indole

1-(Triisopropylsilyl)-1H-indole

C17H27NSi (273.1912662)


   

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

C14H27NO4 (273.1939982)


   

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.1939982)


   

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

C18H24FN (273.1892676)


   

2-Benzyl-8,8-dimethyl-9-oxa-2-azaspiro[5.5]undecane

2-Benzyl-8,8-dimethyl-9-oxa-2-azaspiro[5.5]undecane

C18H27NO (273.2092532)


   

4-methoxyphencyclidine , 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine

4-methoxyphencyclidine , 1-[1-(4-methoxyphenyl)cyclohexyl]-piperidine

C18H27NO (273.2092532)


   

Tetrapropylammonium tetrafluoroborate

Tetrapropylammonium tetrafluoroborate

C12H28BF4N (273.2250806)


   

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

C18H25O2- (273.185445)


   

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde

8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde

C17H23NO2 (273.1728698)


   

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.1939982)


   

Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]

Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]

C17H23NO2 (273.1728698)


   

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

C16H23N3O (273.1841028)


   

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

C16H23N3O (273.1841028)


   

1,3-DI-TERT-BUTYL-2-(TERT-BUTYLAMINO)-1,

1,3-DI-TERT-BUTYL-2-(TERT-BUTYLAMINO)-1,

C12H31N3Si2 (273.2056406)


   

7,7-azanediyldiheptanoic acid

7,7-azanediyldiheptanoic acid

C14H27NO4 (273.1939982)


   

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

C16H24BNO2 (273.1899994)


   

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

C16H24BNO2 (273.1899994)


   

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

C16H23N3O (273.1841028)


   

Dextilidine

Dextilidine

C17H23NO2 (273.1728698)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

C15H23N5 (273.1953358)


   

Tilidine, (-)-

Tilidine, (-)-

C17H23NO2 (273.1728698)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

Tropanserin

Tropanserin

C17H23NO2 (273.1728698)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tropanserin is a serotoninergic active compound, as well as a 5HT3 receptor antagonist. Tropanserin modulates Cardio-respiratory reflex effects of an exogenous serotonin challenge[1].

   

L-Alanine, L-alanyl-L-leucyl-

L-Alanine, L-alanyl-L-leucyl-

C12H23N3O4 (273.1688478)


   

N-[2-[hydroxy(nitroso)amino]-3-methylbutyl]octanamide

N-[2-[hydroxy(nitroso)amino]-3-methylbutyl]octanamide

C13H27N3O3 (273.20523119999996)


   
   

L-Alanyl-L-alanyl-L-leucine

L-Alanyl-L-alanyl-L-leucine

C12H23N3O4 (273.1688478)


   

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

C16H23N3O (273.1841028)


   

5-Dihydrobenzofuranpyrovalerone

5-Dihydrobenzofuranpyrovalerone

C17H23NO2 (273.1728698)


   

5,6-Dimethyl-1-octyl-4-benzimidazolamine

5,6-Dimethyl-1-octyl-4-benzimidazolamine

C17H27N3 (273.2204862)


   

Glycyl-L-valyl-L-valine

Glycyl-L-valyl-L-valine

C12H23N3O4 (273.1688478)


   

N-[2-(cyclohex-1-en-1-yl)-2-(4-methoxyphenyl)ethyl]acetamide

N-[2-(cyclohex-1-en-1-yl)-2-(4-methoxyphenyl)ethyl]acetamide

C17H23NO2 (273.1728698)


   

(9Z,12Z,15Z)-octadecatrien-6-ynoate

(9Z,12Z,15Z)-octadecatrien-6-ynoate

C18H25O2- (273.185445)


   

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

C11H23N5O3 (273.18008080000004)


   

4-Methylhexanoylcarnitine

4-Methylhexanoylcarnitine

C14H27NO4 (273.1939982)


   

5-Methylhexanoylcarnitine

5-Methylhexanoylcarnitine

C14H27NO4 (273.1939982)


   

3-Methylhexanoylcarnitine

3-Methylhexanoylcarnitine

C14H27NO4 (273.1939982)


   

8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dimethylbenzoate

8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dimethylbenzoate

C17H23NO2 (273.1728698)


   

N-Decanoyl-L-Homoserine

N-Decanoyl-L-Homoserine

C14H27NO4 (273.1939982)


   
   
   

(S)-fenpropidin

(S)-fenpropidin

C19H31N (273.2456366)


   
   

2-heptyl-1-methoxy-4(1H)-quinolinone

2-heptyl-1-methoxy-4(1H)-quinolinone

C17H23NO2 (273.1728698)


   

(R)-fenpropidin

(R)-fenpropidin

C19H31N (273.2456366)


   
   
   

1-[4-(2-Methoxyphenoxy)but-2-ynyl]azepane

1-[4-(2-Methoxyphenoxy)but-2-ynyl]azepane

C17H23NO2 (273.1728698)


   

(3R,8Z,11S)-11-methyl-3-phenyl-1-oxa-4-azacyclododec-8-en-12-one

(3R,8Z,11S)-11-methyl-3-phenyl-1-oxa-4-azacyclododec-8-en-12-one

C17H23NO2 (273.1728698)


   
   
   

N-dodecanoyl-(2S)-hydroxyglycine

N-dodecanoyl-(2S)-hydroxyglycine

C14H27NO4 (273.1939982)


   

3-[3-(4-Acetamidobutylamino)propylamino]-3-oxopropanoic acid

3-[3-(4-Acetamidobutylamino)propylamino]-3-oxopropanoic acid

C12H23N3O4 (273.1688478)


   

3-[4-(3-Acetamidopropylamino)butylamino]-3-oxopropanoic acid

3-[4-(3-Acetamidopropylamino)butylamino]-3-oxopropanoic acid

C12H23N3O4 (273.1688478)


   

N-Octylbis(trimethylsilyl)amine

N-Octylbis(trimethylsilyl)amine

C14H35NSi2 (273.230791)


   

N-(1,3-dihydroxytridecan-2-yl)acetamide

N-(1,3-dihydroxytridecan-2-yl)acetamide

C15H31NO3 (273.2303816)


   

N-(1,3-dihydroxynonan-2-yl)hexanamide

N-(1,3-dihydroxynonan-2-yl)hexanamide

C15H31NO3 (273.2303816)


   

N-(1,3-dihydroxyoctan-2-yl)heptanamide

N-(1,3-dihydroxyoctan-2-yl)heptanamide

C15H31NO3 (273.2303816)


   

N-(1,3-dihydroxydodecan-2-yl)propanamide

N-(1,3-dihydroxydodecan-2-yl)propanamide

C15H31NO3 (273.2303816)


   

N-(1,3-dihydroxydecan-2-yl)pentanamide

N-(1,3-dihydroxydecan-2-yl)pentanamide

C15H31NO3 (273.2303816)


   

N-(1,3-dihydroxyundecan-2-yl)butanamide

N-(1,3-dihydroxyundecan-2-yl)butanamide

C15H31NO3 (273.2303816)


   

N-Para-octylphenyl-2-pyrrolidone

N-Para-octylphenyl-2-pyrrolidone

C18H27NO (273.2092532)


   

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

N-Isobutyl-2,4,8,10,12-tetradecapentaenamide

C18H27NO (273.2092532)


   

O-heptanoylcarnitine

O-heptanoylcarnitine

C14H27NO4 (273.1939982)


An O-acylcarnitine that is the O-heptanoyl derivative of carnitine.

   
   

alpha-Terpinyl anthranilate

alpha-Terpinyl anthranilate

C17H23NO2 (273.1728698)


   

tropanyl 3,5-dimethylbenzoate

tropanyl 3,5-dimethylbenzoate

C17H23NO2 (273.1728698)


A tropane alkaloid that consists of tropine in which the hydrogen of the hydroxy function is substituted by a 3,5-dimethylbenzoyl group.

   

2-Heptyl-1-methoxyquinolin-4(1H)-one

2-Heptyl-1-methoxyquinolin-4(1H)-one

C17H23NO2 (273.1728698)


   

1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine

1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine

C18H27NO (273.2092532)


   
   
   
   
   
   
   

Cevimeline (hydrochloride hemihydrate)

Cevimeline (hydrochloride hemihydrate)

C10H17NOS.HCl.1/2H2O (273.24681300000003)


Cevimeline hydrochloride hemihydrate (SNI-2011) is a quinuclidine derivative of acetylcholine and a selective and orally active muscarinic M1 and M3 receptor agonist. Cevimeline hydrochloride hemihydrate stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia[1][2][3][4]. Cevimeline hydrochloride hemihydrate can cross the blood-brain barrier (BBB)[5].

   

4-{2-[(5-methoxy-2-methylcyclohex-2-en-1-yl)(methyl)amino]ethenyl}phenol

4-{2-[(5-methoxy-2-methylcyclohex-2-en-1-yl)(methyl)amino]ethenyl}phenol

C17H23NO2 (273.1728698)


   

(1s,4s,10r,12r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10r,12r)-9-(hex-2-en-1-yl)-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2204862)


   

(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

C17H23NO2 (273.1728698)


   

5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

C17H23NO2 (273.1728698)


   

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

C18H27NO (273.2092532)


   

(3e)-4-{2-[(1e)-3-hydroxyhex-1-en-1-yl]-4-methylphenyl}but-3-enimidic acid

(3e)-4-{2-[(1e)-3-hydroxyhex-1-en-1-yl]-4-methylphenyl}but-3-enimidic acid

C17H23NO2 (273.1728698)


   

n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

C18H27NO (273.2092532)


   

(3e,5e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

(3e,5e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

C17H23NO2 (273.1728698)


   

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

C17H23NO2 (273.1728698)


   

(3e)-4-[4-methyl-2-(3-oxohexyl)phenyl]but-3-enimidic acid

(3e)-4-[4-methyl-2-(3-oxohexyl)phenyl]but-3-enimidic acid

C17H23NO2 (273.1728698)


   

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8-yn-1-one

C18H27NO (273.2092532)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-2-methylpropanimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]-2-methylpropanimidic acid

C17H23NO2 (273.1728698)


   

(1s,3s,8s,9r,12s)-5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

(1s,3s,8s,9r,12s)-5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione

C17H23NO2 (273.1728698)


   

n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2092532)


   

n-[(2s)-2-[hydroxy(nitroso)amino]-3-methylbutyl]octanimidic acid

n-[(2s)-2-[hydroxy(nitroso)amino]-3-methylbutyl]octanimidic acid

C13H27N3O3 (273.20523119999996)


   

5-(7-methylnonyl)-1,2,3,4-tetrahydroquinoline

5-(7-methylnonyl)-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456366)


   

(2e,4e,8z,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2092532)


   

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO2 (273.1728698)


   

4-[(1z)-2-{[(1s,5s)-5-methoxy-2-methylcyclohex-2-en-1-yl](methyl)amino}ethenyl]phenol

4-[(1z)-2-{[(1s,5s)-5-methoxy-2-methylcyclohex-2-en-1-yl](methyl)amino}ethenyl]phenol

C17H23NO2 (273.1728698)


   

(2e,4e,8z,11z)-1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

(2e,4e,8z,11z)-1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

C18H27NO (273.2092532)


   

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate

C17H23NO2 (273.1728698)


   

(2e,4e,8z,10e,12e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-[(2s)-butan-2-yl]tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2092532)


   

5-decyl-1,2,3,4-tetrahydroquinoline

5-decyl-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456366)


   

(2e,6e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,6,8,10,12-pentaenimidic acid

(2e,6e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,6,8,10,12-pentaenimidic acid

C18H27NO (273.2092532)


   

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H27N3 (273.2204862)


   

(1s,4s,10s,12r)-9-[(1e)-hex-1-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10s,12r)-9-[(1e)-hex-1-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2204862)


   

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

C17H23NO2 (273.1728698)


   

5-(8-methylnonyl)-1,2,3,4-tetrahydroquinoline

5-(8-methylnonyl)-1,2,3,4-tetrahydroquinoline

C19H31N (273.2456366)


   

4-hydroxy-2-octylquinolin-1-ium-1-olate

4-hydroxy-2-octylquinolin-1-ium-1-olate

C17H23NO2 (273.1728698)


   

(1s,4s,10r,12r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

(1s,4s,10r,12r)-9-[(2z)-hex-2-en-1-yl]-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-6-imine

C17H27N3 (273.2204862)


   

n-{2-[hydroxy(nitroso)amino]-3-methylbutyl}octanimidic acid

n-{2-[hydroxy(nitroso)amino]-3-methylbutyl}octanimidic acid

C13H27N3O3 (273.20523119999996)


   

(2e,4e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8e,10e,12e)-n-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenimidic acid

C18H27NO (273.2092532)


   

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid

C17H23NO2 (273.1728698)


   

(2e)-n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

(2e)-n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

C18H27NO (273.2092532)


   

(z)-(hydroxyimino)({1-[(1-hydroxyoctylidene)amino]-3-methylbutan-2-yl})oxidoazanium

(z)-(hydroxyimino)({1-[(1-hydroxyoctylidene)amino]-3-methylbutan-2-yl})oxidoazanium

C13H27N3O3 (273.20523119999996)


   

(4s)-4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

(4s)-4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one

C17H23NO2 (273.1728698)


   

1-(4-isopropylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

1-(4-isopropylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

C18H27NO (273.2092532)


   

(2e,4e,10z)-n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

(2e,4e,10z)-n-(2-methylpropyl)tetradeca-2,4,10-trien-8-ynimidic acid

C18H27NO (273.2092532)


   

1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4,8,11-tetraen-1-one

C18H27NO (273.2092532)


   

(1s,2r,4r,8s,9r,11s)-8-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-3-oxa-7-azatetracyclo[5.4.0.0²,⁴.0⁹,¹¹]undecan-1-ol

(1s,2r,4r,8s,9r,11s)-8-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-3-oxa-7-azatetracyclo[5.4.0.0²,⁴.0⁹,¹¹]undecan-1-ol

C17H23NO2 (273.1728698)


   

n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

n-(2-methylpropyl)tetradec-2-en-10,12-diynimidic acid

C18H27NO (273.2092532)


   

(1s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

(1s,9r,10r)-9-butyl-10-propyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine

C17H27N3 (273.2204862)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylpropanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylpropanoate

C17H23NO2 (273.1728698)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]butanimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]butanimidic acid

C17H23NO2 (273.1728698)


   

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid

C17H23NO2 (273.1728698)


   

(2e,8e)-7-hydroxy-n-(2-methylpropyl)trideca-2,8-dien-10,12-diynimidic acid

(2e,8e)-7-hydroxy-n-(2-methylpropyl)trideca-2,8-dien-10,12-diynimidic acid

C17H23NO2 (273.1728698)


   

2-hexyl-8-methoxy-1-methylquinolin-4-one

2-hexyl-8-methoxy-1-methylquinolin-4-one

C17H23NO2 (273.1728698)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one

C17H23NO2 (273.1728698)